@article{Antunes2024Effectiveness,
author = {Antunes, Liliana and Mazagatos, Clara and Martínez-Baz, Iván and Gomez, Verónica and Borg, Maria-Louise and Petrović, Goranka and Duffy, Róisín and Dufrasne, François E. and Dürrwald, Ralf and Lazar, Mihaela and Jancoriene, Ligita and Oroszi, Beatrix and Husa, Petr and Howard, Jennifer and Melo, Aryse and Pozo, Francisco and Pérez-Gimeno, Gloria and Castilla, Jesús and Machado, Ausenda and Džiugytė, Aušra and Karabuva, Svjetlana and Fitzgerald, Margaret and Fierens, Sébastien and Tolksdorf, Kristin and Popovici, Silvia-Odette and Mickienė, Auksė and Túri, Gergő and Součková, Lenka and Nicolay, Nathalie and Rose, Angela M.C. and on behalf of the European Hospital Vaccine Effectiveness Group},
title = {Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023},
journal = {Eurosurveillance - Europe's journal on infectious disease surveillance, epidemiology, prevention and control},
pages = {1--8},
year = {2024},
doi = {10.2807/1560-7917.ES.2024.29.3.2300708}
}